Jelena Vekić, PhD

Dr sc. Jelena Vekić

Position: Associate professor
Organizational unit:
Department of Medical Biochemistry
Address:
Vojvode Stepe 450, 11221 Beolgrade, Serbia
Room:
A206
Phone: 
+381 113951 266
Email:
 jelena.vekic@pharmacy.bg.ac.rs

CV


Jelena Vekić works at Faculty of Pharmacy since 2003. She is engaged in teaching of several obligatory and elective courses at integrated academic studies, PhD studies and specialist studies at the Faculty. Her scientific interest is focused on structure-functional properties of lipoproteins, molecular mechanisms involved in the regulation of lipid/lipoprotein metabolism and clinical significance of novel lipid biomarkers. Main areas of her research include: atherosclerosis, cardiovascular disease, obesity, metabolic syndrome and diabetes. She published two book chapters, more than 60 papers in international journals, and two university textbooks.

.

  • Vekic J, Zeljkovic A, Stefanovic A, Giglio RV, Ciaccio M, Rizzo M. Diabetes and colorectal cancer risk: a new look at molecular mechanisms and potential role of novel antidiabetic agents. Int  J  Mol Sci 2021; 22: 12409.
  • Zeljkovic A, Vekic J, Mihajlovic M, Gojkovic T, Vladimirov S, Zeljkovic D, Spasojevic-Kalimanovska V, Trifunovic B. Revealing the role of high-density lipoprotein in colorectal cancer. Int J Mol Sci 2021;22:3352.
  • Perovic Blagojevic IM, Vekic JZ, Macut DP, Ignjatovic SD, Miljkovic-Trailovic MM, Zeljkovic AR, Spasojevic-Kalimanovska VV, Bozic-Antic IB, Bjekic-Macut JD, Kastratovic-Kotlica BA, Andric ZG, Ilic DS, Kotur-Stevuljevic JM. Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia. Br J Nutr 2021:1-9.
  • Kotur-Stevuljević J, Vekić J, Stefanović A, Zeljković A, Ninić A, Ivanišević J, Miljković M, Sopić M, Munjas J, Mihajlović M, Spasić S, Jelić-Ivanović Z, Spasojević-Kalimanovska V. Paraoxonase 1 and atherosclerosis-related diseases. Biofactors. 2020;46:193-205.
  • Zeljkovic A, Mihajlovic M, Stefanovic A, Zeljkovic D, Trifunovic B, Miljkovic M, Spasojevic-Kalimanovska V, Vekic J. Potential use of serum insulin-like growth factor 1 and E-cadherin as biomarkers of colorectal cancer. Colorectal Dis 2020;22:2078-2086.
  • Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V. Obesity and dyslipidemia. Metabolism 2019; 92: 71-81.
  • Bojanin D, Vekic J, Milenkovic T, Vukovic R, Zeljkovic A, Stefanovic A, Janac J, Ivanisevic J, Mitrovic K, Miljkovic M, Spasojevic-Kalimanovska V. Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: effects of glycemic control. Atherosclerosis 2019; 280: 14-20.
  • Vukovic R, Zeljkovic A, Bufan B, Spasojevic-Kalimanovska V, Milenkovic T, Vekic J. Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review. Front Endocrino. 2019;10:868.
  • Stevanovic M, Vekic J, Bogavac-Stanojevic N, Janac J, Stjepanovic Z, Zeljkovic D, Trifunovic B, Spasojevic-Kalimanovska V, Zeljkovic A. Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development. Biochem Med 2018;28(3):030713.
  • Bojanin D, Milenkovic T, Vekic J, Vukovic R, Zeljkovic A, Janac J, Ivanisevic J, Todorovic S, Mazibrada I, Spasojevic-Kalimanovska V. Effects of co-existing autoimmune diseases on serum lipids and lipoprotein subclasses profile in paediatric patients with type 1 diabetes mellitus. Clin Biochem 2018; 54: 11-17.